Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - frances jensen
Therapeutic to mitigate epilepsy and autism development in newborn seizure patients
Neonatal brains are at high risk for seizures due to heightened electrical activity corresponding to neural development. Though anticonvulsant drugs exist to treat the seizures immediately, certain synaptic receptors (CP-AMPARs) become highly expressed, increasing the likelihood of developing epilepsy and autism-spectrum disorders. The inventors propose...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by